TG Therapeutics, Inc. (TGTX) Form 8-K Summary

Date of Report: November 3, 2025

This Form 8-K serves as notification that TG Therapeutics, Inc. furnished Exhibit 99.1, containing its press release detailing operational results for the three and nine months ended September 30, 2025.

• Material Event: Release of Q3 2025 financial performance data.
• Investor Action: Investors must refer to the furnished Exhibit 99.1 press release for specific financial metrics, performance commentary, and strategic updates.
• Filing Caveat: Information in Item 2.02 is furnishe